Neuropeptide Y T1128C polymorphism: an independent predictor of hypertensive and cardiovascular diseases?
- PMID: 15201537
- PMCID: PMC2277519
- DOI: 10.1097/01.hjh.0000125471.35523.ad
Neuropeptide Y T1128C polymorphism: an independent predictor of hypertensive and cardiovascular diseases?
Comment on
-
Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population.J Hypertens. 2004 Jul;22(7):1277-81. doi: 10.1097/01.hjh.0000125415.50839.7b. J Hypertens. 2004. PMID: 15201542
Similar articles
-
Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population.J Hypertens. 2004 Jul;22(7):1277-81. doi: 10.1097/01.hjh.0000125415.50839.7b. J Hypertens. 2004. PMID: 15201542
-
Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population.J Hypertens. 2004 Dec;22(12):2398-9; author reply 2399-400. doi: 10.1097/00004872-200412000-00025. J Hypertens. 2004. PMID: 15614037 No abstract available.
-
Neuropeptide Y gene functional polymorphism influences susceptibility to hypertension in Indian population.J Hum Hypertens. 2010 Sep;24(9):617-22. doi: 10.1038/jhh.2009.104. Epub 2009 Dec 24. J Hum Hypertens. 2010. PMID: 20033074
-
NPY L7P polymorphism and metabolic diseases.Regul Pept. 2008 Aug 7;149(1-3):51-5. doi: 10.1016/j.regpep.2007.08.028. Epub 2008 Apr 3. Regul Pept. 2008. PMID: 18499283 Review.
-
[Genetic aspects of hypertension--etiology of essential hypertension].Nihon Naika Gakkai Zasshi. 1995 Jul 10;84(7):1172-7. Nihon Naika Gakkai Zasshi. 1995. PMID: 7561378 Review. Japanese. No abstract available.
Cited by
-
Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's disease.J Neural Transm (Vienna). 2006 Feb;113(2):231-8. doi: 10.1007/s00702-005-0319-z. Epub 2005 Jun 15. J Neural Transm (Vienna). 2006. PMID: 15959845
References
-
- Michel MC, Rascher W. Neuropeptide Y: a possible role in hypertension? J Hypertens. 1995;13:385–395. - PubMed
-
- Tatemoto KM, Carlquist M, Mutt V. Neuropeptide Y: a novel brain peptide with structural similarities to peptide YY and pancreatic peptide. Nature. 1982;296:659–660. - PubMed
-
- Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, et al. Neuropeptide Y distribution in the rat brain. Science. 1983;221:877–879. - PubMed
-
- Odar-Cederlof I, Ericsson F, Theodorsson E, Kjellstrand CM. Is neuropeptide Y a contributor to volume-induced hypertension? Am J Kidney Dis. 1998;31:803–808. - PubMed
-
- Zukowska Z, Pons J, Lee EW, Li L. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? Can J Physiol Pharmacol. 2003;81:89–94. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical